1.
Miura Y, Saito T, Fujita K, Tanaka T, Tsunoda Y, Azuma A, et al. Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2014 Oct. 20 [cited 2024 Jul. 4];31(3):235-8. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/3326